<noframes id="zd9f3">

    <address id="zd9f3"></address>

    <address id="zd9f3"></address>
    <address id="zd9f3"></address>

    <address id="zd9f3"><nobr id="zd9f3"><meter id="zd9f3"></meter></nobr></address>
    1. Cell Cycle/DNA Damage
    2. PAK


    PAKs (p21-activated kinases) are key regulators of actin dynamics, cell proliferation and cell survival. PAKs are Ser/Thr kinases that are classified into two groups on the basis of their structural and functional features: group I (PAK1–3) and group II (PAK4–6). Group I PAKs have an auto-inhibitory domain (also called an inhibitory switch domain) and a kinase domain (catalytic domain, CD) and are activated by the binding of the active (that is, GTP-bound) forms of Rho GTPases, such as Cdc42 and Rac1. Group II PAKs have no auto-inhibitory domains and are not activated by active Rho GTPases. Because the deregulation of PAKs is closely associated with various human diseases,small-molecule inhibitors of these kinases have great potential as therapeutic agents. In addition, these compounds can also be used as powerful tools in studies aimed at understanding the PAK signaling pathway.

    PAKs are considered prime regulators of the actin cytoskeleton and motility. Due to their central role in actin remodelling and their ability to activate Matrix metalloproteinases (MMPs), Rho GTPases play an important role in tumor cell invasion and metastasis. The current evidence suggests the involvement of PAKs in motility, cell survival, anchorage-independent growth, angiogenesis, invasion, migration and regulation of cell cycle and mitosis. Consequently, PAKs have also been implicated in a number of pathological conditions including cancer.

    PAK Isoform Specific Products:

    • PAK1

    • PAK2

    • PAK3

    • PAK4

    • PAK5

    • PAK6

    PAK 相关产品 (11):

    Cat. No. Product Name Effect Purity
    • HY-13007
      PF-3758309 Inhibitor 98.41%
      PF-3758309 是一种有效的 PAK 抑制剂,能够抑制 PAK4 的活性,IC50 值为 1.3 nM。
    • HY-15542B
      FRAX486 Inhibitor >98.0%
      FRAX486 是一种 PAK抑制剂,对 PAK1,PAK2 和 PAK3 的 IC50 值分别为 14,33 和 39 nM。
    • HY-15663
      IPA-3 Inhibitor >98.0%
      IPA-3 是一种选择性的,ATP 非竞争的 PAK1 抑制剂,IC50 值为 2.5 μM,对 PAKs 4-6 没有抑制作用。
    • HY-19635
      G-5555 Inhibitor 99.18%
      G-5555 是有效 PAK1 抑制剂,对 PAK1 和 PAK2 的 Ki 值分别为 3.7 nM 和 11 nM。
    • HY-15027
      5-Aminosalicylic Acid Inhibitor >98.0%
      5-Aminosalicylic acid 是一种特异性的 PPARγ 激动剂,还抑制 p21-激活激酶1 (PAK1) 和 NF-κB
    • HY-15542A
      FRAX597 Inhibitor 99.02%
      FRAX597 是一种有效的 I型 P21激活激酶 (PAK)抑制剂,作用于 PAK123IC50 分别为 8,13 和 19 nM。
    • HY-19538
      FRAX1036 Inhibitor >98.0%
      FRAX1036 是一种 PAK 抑制剂,对 PAK1,PAK2 和 PAK4 的 Ki 值分别为 23.3 nM,72.4 nM 和 2.4 μM。
    • HY-12793
      KPT-9274 Inhibitor 99.28%
      KPT-9274是有口服活性的 PAK4/烟酰胺磷酸核糖基转移酶 (Nampt) 抑制剂,IC50 值分别为小于 100 和 125 nM。
    • HY-100519
      NVS-PAK1-1 Inhibitor 99.82%
      NVS-PAK1-1是有效,选择性的 PAK1 变构抑制剂,IC50值为5 nM。
    • HY-19635A
      G-5555 hydrochloride Inhibitor 98.19%
      G-5555 hydrochloride是有效,选择性的PAK1抑制剂,Ki值为3.7 nM。
    • HY-12632
      PAK-IN-1 Inhibitor
      PAK-IN-1 是 PAK 的抑制剂,对 group II 具有选择性。PAK-IN-1抑制 PAK4,PAK5 和 PAK6 的 IC50 值分别为7.5,36和126 nM。
    Isoform Specific Products

    Your Search Returned No Results.

    Sorry. There is currently no product that acts on isoform together.

    Please try each isoform separately.